Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.50 |
| ▸ | ACACB | O00763 | 2/20 | 0.49 |
| ▸ | ACACA | Q13085 | 2/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | LPL | P06858 | 1/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8623292 | 0.85 | THRB (0.45) | THRBACACBACACALPLLIPG | |
| SCHEMBL8625001 | 0.78 | THRB (0.54) | THRBLPLLIPGKMT2AALDH1A1 | |
| SCHEMBL8947004 | 0.77 | ACACB (0.52) | THRBACACBACACAKMT2AALDH1A1 | |
| SCHEMBL2202805 | 0.77 | THRB (0.52) | THRBACACBACACALPLLIPG | |
| SCHEMBL8618583 | 0.76 | SRD5A2 (0.50) | ACACBACACAHRH3RAB9A | |
| SCHEMBL11882175 | 0.76 | TSHR (0.45) | HRH3LPLLIPGALDH1A1 | |
| SCHEMBL12090743 | 0.76 | ACACB (0.52) | THRBACACBACACALPLLIPG | |
| SCHEMBL10502158 | 0.76 | ADRB2 (0.41) | THRBACACBACACAHRH3KMT2A | |
| SCHEMBL8618596 | 0.75 | RARB (0.50) | THRBLPLLIPGKMT2AALDH1A1 | |
| SCHEMBL1689680 | 0.72 | CA1 (0.46) | HRH3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5712396-A | PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS | MAGNIN DAVID R (US) | 1998-01-27 | — | — | US | disclosed |
| US-5470845-A | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-28 | — | — | US | disclosed |
| EP-0595635-A1 | Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors | E.R. Squibb & Sons, Inc. (US) | 1994-05-04 | — | — | EP | disclosed |